Epigenetic regulator controlling the very first cell fate decision in human embryonic development identifiedEpigenetic regulator controlling the very first cell fate decision in human embryonic development identifiedEpigenetic regulator controlling the very first cell fate decision in human embryonic development identifiedEpigenetic regulator controlling the very first cell fate decision in human embryonic development identified
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Robot

  • Home
  • News
  • Related Science News
  • Robot
June 3, 2022
June 3, 2022

Epigenetic regulator controlling the very first cell fate decision in human embryonic development identified

Do you like it?
Read more
June 2, 2022
June 2, 2022

New plans to use machine learning to improve cancer treatments

Do you like it?
Read more
June 2, 2022
June 2, 2022

Exposure to chemicals increased in pregnant women in the last decade, study suggests

Do you like it?
Read more
June 2, 2022
June 2, 2022

High-fat diet, unregulated athletic exercise endurance enhancers linked to risk of pancreatic cancer

Do you like it?
Read more
June 2, 2022
June 2, 2022

Food allergy is associated with a lower risk of SARS-CoV-2 infection

Do you like it?
Read more
June 2, 2022
June 2, 2022

Gene therapy for rare eye disease safe but lacks efficacy in early trial

Do you like it?
Read more
June 2, 2022
June 2, 2022

Combination anti-HIV antibody infusions suppress virus for prolonged period

Do you like it?
Read more
June 2, 2022
June 2, 2022

Investigational drug attacks synovial sarcoma, a rare type of tumor

Do you like it?
Read more
June 2, 2022
June 2, 2022

Experimental drug reverses synaptic loss in mouse models of Alzheimer’s

Do you like it?
Read more
June 2, 2022
June 2, 2022

Antibiotics wreak havoc on athletic performance

Do you like it?
Read more
June 2, 2022
June 2, 2022

Alzheimer’s disease causes cells to overheat and ‘fry like eggs’

Do you like it?
Read more
June 2, 2022
June 2, 2022

How Sleep Builds Relational Memory

Do you like it?
Read more
June 2, 2022
June 2, 2022

New cancer subtype may illuminate treatment strategy

Do you like it?
Read more
June 2, 2022
June 2, 2022

CBD is not going to impair your driving ability, even at high doses

Do you like it?
Read more
June 1, 2022
June 1, 2022

Decoding how a protein on the move keeps cells healthy

Do you like it?
Read more
June 1, 2022
June 1, 2022

Screening every five years safe for women who test negative for HPV, study confirms

Do you like it?
Read more
June 1, 2022
June 1, 2022

Convenience-sized RNA editing

Do you like it?
Read more
June 1, 2022
June 1, 2022

SMART researchers enable early-stage detection of microbial contamination in cell therapy

Do you like it?
Read more
June 1, 2022
June 1, 2022

Nerve stimulation promotes resolution of inflammation

Do you like it?
Read more
June 1, 2022
June 1, 2022

Researchers look to unleash the power of stem cells to repair brain injuries

Do you like it?
Read more
June 1, 2022
June 1, 2022

Roundworms offer new insights into Bardet-Biedl syndrome

Do you like it?
Read more
June 1, 2022
June 1, 2022

How intricate patterns arise in developing tissues

Do you like it?
Read more
June 1, 2022
June 1, 2022

Building a human ‘pangenome’ to capture global genomic diversity

Do you like it?
Read more
June 1, 2022
June 1, 2022

COVID-19 can damage a very important part of the heart

Do you like it?
Read more
May 31, 2022
May 31, 2022

Ageing drugs could prevent some side effects of cancer treatment

Do you like it?
Read more
May 31, 2022
May 31, 2022

T cell warriors need their R & R

Do you like it?
Read more
May 31, 2022
May 31, 2022

Pain, anxiety should be dealt with soon after MS diagnosis

Do you like it?
Read more
May 31, 2022
May 31, 2022

The secret to a longer lifespan? Gene regulation holds a clue

Do you like it?
Read more
May 31, 2022
May 31, 2022

The Paired Perils of Breast Cancer and Diabetes

Do you like it?
Read more
May 30, 2022
May 30, 2022

Chemists reveal how tau proteins form tangles

Do you like it?
Read more
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311
Next page
© 2017 - 2025 Innovita Research | Privacy policy